BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22850586)

  • 1. In reply to Vergier et al: fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
    Kittler H
    Mod Pathol; 2012 Aug; 25(8):1176; author reply 1176-7. PubMed ID: 22850586
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
    Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
    Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Debating melanocytic tumors of the skin: does an "uncertain" diagnosis signify borderline diagnostic skill?
    Foucar E
    Am J Dermatopathol; 1995 Dec; 17(6):626-34. PubMed ID: 8599482
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrating clinical/dermatoscopic findings and fluorescence in situ hybridization in diagnosing melanocytic neoplasms with less than definitive histopathologic features.
    Nardone B; Martini M; Busam K; Marghoob A; West DP; Gerami P
    J Am Acad Dermatol; 2012 Jun; 66(6):917-22. PubMed ID: 21962759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
    Zembowicz A; Yang SE; Kafanas A; Lyle SR
    Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocytic Lesions: Current State of Knowledge? Part II.
    Zembowicz A; Prieto VG
    Arch Pathol Lab Med; 2011 Mar; 135(3):298-9. PubMed ID: 21366451
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular diagnostics for ambiguous melanocytic tumors.
    Shahbain H; Cooper C; Gerami P
    Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular testing for melanocytic tumors: a practical update.
    Andea AA
    Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanocytic aggregation in the skin: diagnostic clues from lentigines to melanoma.
    de Giorgi V; Sestini S; Massi D; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):303-20, vii-viii. PubMed ID: 17662896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nevus/Melanocytoma/Melanoma: an emerging paradigm for classification of melanocytic neoplasms?
    Zembowicz A; Scolyer RA
    Arch Pathol Lab Med; 2011 Mar; 135(3):300-6. PubMed ID: 21366452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors.
    Ponti G; Ruini C; Massi D; Pellacani G; Tomasi A; Paglierani M; Loschi P; Seidenari S
    Melanoma Res; 2013 Dec; 23(6):474-80. PubMed ID: 24077512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
    Gammon B; Gerami P
    Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
    Senetta R; Paglierani M; Massi D
    Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous melanocytic tumors. Case 2].
    Castillo C
    Ann Pathol; 2016 Oct; 36(5):322-325. PubMed ID: 27639774
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical application and limitations of the fluorescence in situ hybridization (FISH) assay in the diagnosis and management of melanocytic lesions: a report of 3 cases.
    Nijhawan RI; Votava HJ; Mariwalla K
    Cutis; 2012 Oct; 90(4):189-95. PubMed ID: 23259206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic reproducibility of melanocytic dysplasia.
    Piepkorn M
    Arch Dermatol; 1998 Aug; 134(8):1037-9. PubMed ID: 9722743
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous melanocytic dysplasia and malignant melanoma. A critical review.
    Kwittken J
    J Med; 1991; 22(1):1-16. PubMed ID: 2072047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technologies for the diagnosis of primary melanoma of the skin.
    Menzies SW
    Med J Aust; 2006 Nov; 185(10):533-4. PubMed ID: 17115962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologically distinct subsets of nevi.
    Rogers T; Marino ML; Raciti P; Jain M; Busam KJ; Marchetti MA; Marghoob AA
    G Ital Dermatol Venereol; 2016 Aug; 151(4):365-84. PubMed ID: 27119653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.